41.74 USD
+0.44 (+1.07%)
37.72 USD
-4.02 (-9.63%)
Taking everything into account, PDEX scores 5 out of 10 in our fundamental rating. PDEX was compared to 185 industry peers in the Health Care Equipment & Supplies industry. PDEX has an excellent profitability rating, but there are some minor concerns on its financial health. PDEX has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PDEX was profitable.
PDEX had a negative operating cash flow in the past year.
In the past 5 years PDEX has always been profitable.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of PDEX (17.41%) is better than 98.38% of its industry peers.
PDEX has a Return On Equity of 26.96%. This is amongst the best in the industry. PDEX outperforms 97.84% of its industry peers.
PDEX's Return On Invested Capital of 16.51% is amongst the best of the industry. PDEX outperforms 96.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PDEX is significantly above the industry average of 8.84%.
The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(16.51%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROIC | 16.51% |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
1.3 Margins
Looking at the Profit Margin, with a value of 15.94%, PDEX belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
In the last couple of years the Profit Margin of PDEX has declined.
PDEX has a Operating Margin of 15.36%. This is amongst the best in the industry. PDEX outperforms 83.78% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 28.09%, PDEX is not doing good in the industry: 76.76% of the companies in the same industry are doing better.
PDEX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% |
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
2. Health
2.1 Basic Checks
PDEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, PDEX has less shares outstanding
The number of shares outstanding for PDEX has been reduced compared to 5 years ago.
The debt/assets ratio for PDEX is higher compared to a year ago.
2.2 Solvency
PDEX has an Altman-Z score of 6.81. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
PDEX's Altman-Z score of 6.81 is amongst the best of the industry. PDEX outperforms 83.24% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that PDEX is not too dependend on debt financing.
PDEX's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. PDEX outperforms 57.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.81 |
ROIC/WACC1.7
WACC9.73%
2.3 Liquidity
PDEX has a Current Ratio of 3.73. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.73, PDEX is in the better half of the industry, outperforming 65.41% of the companies in the same industry.
PDEX has a Quick Ratio of 2.14. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX has a Quick ratio of 2.14. This is comparable to the rest of the industry: PDEX outperforms 57.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.14%, which is quite impressive.
Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
Looking at the last year, PDEX shows a very strong growth in Revenue. The Revenue has grown by 23.65%.
PDEX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.84% yearly.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 13.08, which indicates a correct valuation of PDEX.
92.43% of the companies in the same industry are more expensive than PDEX, based on the Price/Earnings ratio.
PDEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.19.
PDEX is valuated rather expensively with a Price/Forward Earnings ratio of 17.19.
Based on the Price/Forward Earnings ratio, PDEX is valued cheaply inside the industry as 85.95% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of PDEX to the average of the S&P500 Index (23.92), we can say PDEX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.08 | ||
| Fwd PE | 17.19 |
4.2 Price Multiples
90.27% of the companies in the same industry are more expensive than PDEX, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.7 |
4.3 Compensation for Growth
The decent profitability rating of PDEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.19
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
PDEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
41.74
+0.44 (+1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners31.88%
Inst Owner Change0%
Ins Owners36.03%
Ins Owner Change1.64%
Market Cap136.07M
Revenue(TTM)70.23M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (36.85%)
Short Float %10.16%
Short Ratio4.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.08 | ||
| Fwd PE | 17.19 | ||
| P/S | 1.94 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.28 | ||
| P/tB | 3.28 | ||
| EV/EBITDA | 10.7 |
EPS(TTM)3.19
EY7.64%
EPS(NY)2.43
Fwd EY5.82%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.54
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)1.19
Graham Number30.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROCE | 21.27% | ||
| ROIC | 16.51% | ||
| ROICexc | 20.85% | ||
| ROICexgc | 20.86% | ||
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% | ||
| FCFM | N/A |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 73.12% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 12.57 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 6.81 |
F-Score6
WACC9.73%
ROIC/WACC1.7
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A
PRO-DEX INC / PDEX FAQ
Can you provide the ChartMill fundamental rating for PRO-DEX INC?
ChartMill assigns a fundamental rating of 5 / 10 to PDEX.
What is the valuation status for PDEX stock?
ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.
Can you provide the profitability details for PRO-DEX INC?
PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.
What is the financial health of PRO-DEX INC (PDEX) stock?
The financial health rating of PRO-DEX INC (PDEX) is 6 / 10.
What is the expected EPS growth for PRO-DEX INC (PDEX) stock?
The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.